Biocapitalism and the Politics of Life MA Peters, P Venkatesan Geopolitics, History, and International Relations 2 (2), 100-122, 2010 | 31 | 2010 |
Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer? P Hays Future Oncology, 2020 | 20 | 2020 |
“Nanoselves”: NBIC and the Culture of Convergence P Venkatesan Bulletin of Science, Technology & Society 30 (2), 119-129, 2010 | 18 | 2010 |
Advancing healthcare through personalized medicine P Hays Crc Press, 2017 | 16 | 2017 |
Making science accessible: A semiotics of scientific communication CH Lowrey, P Venkatesan Biosemiotics 1, 253-269, 2008 | 14 | 2008 |
Epistemic Cross Talk: Why We Need—and Should Desire—Interdisciplinarity PV Hays Interdisciplinary Literary Studies 15 (2), 221-239, 2013 | 7 | 2013 |
Clinical care of chimeric antigen receptor T-cell patients and managing immune-related adverse effects in the ambulatory and hospitalized setting: a review P Hays, C Costello, D Asudani Future Oncology 15 (36), 4235-4246, 2019 | 6 | 2019 |
BIOECONOMY AND THIRD INDUSTRIAL REVOLUTION IN THE AGE OF SYNTHETIC LIFE. MA Peters, P Venkatesan Contemporary Readings in Law & Social Justice 2 (2), 2011 | 6 | 2011 |
Personalized medicine: paradigm shift or revolution P Hays Genetics in Medicine 21 (7), 1662-1662, 2019 | 5 | 2019 |
Review of therapeutic approaches for B-cell malignancies with immune checkpoint blockade and chimeric antigen receptor T-cell therapies: development, benefits, and limitations P Hays J Clin Invest Stud 2, 1-6, 2019 | 5 | 2019 |
Whence social determinants of health?: effective personalized medicine and the 2010 Patient Protection and Affordable Care Act PV Hays | 4 | 2013 |
Reception Studies in France: Social Contexts, Reader Interpretation, and the Role of Julia Kristeva P Venkatesan L'Esprit Créateur 49 (1), 111-124, 2009 | 4 | 2009 |
The legitimation of local knowledges: introducing the postmodern into laboratory science P Venkatesan Social Semiotics 18 (4), 481-491, 2008 | 4 | 2008 |
Trends in precision oncology and precision medicine 2.0 P Hays, P Hays Advancing Healthcare through Personalized Medicine, 419-480, 2021 | 3 | 2021 |
11 Genomics, social formations and subjectivity P Venkatesan New Genetics, New Identities, 177, 2006 | 3 | 2006 |
Molecular Biology in Narrative Form: A Study of the Experimental Trajectory of Science P Hays, PV Hays Peter Lang, 2006 | 3 | 2006 |
Evidence basis for pharmacogenetic testing in psychiatry P Hays Jour Med Resh and Health Sci 5 (3), 1838-1859, 2022 | 2 | 2022 |
Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies P Hays Springer Nature, 2022 | 1 | 2022 |
Cancer Immunotherapies P Hays Allogeneic tumor antigen-specific T cells for broadly applicable adoptive …, 2022 | 1 | 2022 |
Alliances: Knowledge Infrastructures, and the Digitization of Precision Health P Hays, P Hays Advancing Healthcare Through Personalized Medicine, 99-139, 2021 | 1 | 2021 |